Evaluate in vivo prophylactic and therapeutic efficacy of a RNAi-based drug against highly pathogenic influenza A (HPIA) virus, H5N1 (A/Viet Nam/1203/2004)

Project: Other project

Project Details

StatusActive
Effective start/end date6/1/23 → 5/31/24

Funding

  • Arrowhead Pharmaceuticals Inc: $104,284.00